Santé log

Olema Oncology Announces Closing of $218.5 Million Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, ...
Santé log

Inhibikase Therapeutics Advancing IKT-001 to Global Phase 3 Study in Pulmonary Arterial Hypertension

Single Pivotal Study Accelerates Potential FDA Approval Timeline by Approximately 3 Years ...
Santé log

Channel Medsystems Appoints Robert Brown, MBA, CPA, as Chief Financial Officer

BERKELEY, Calif., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Channel Medsystems, Inc., a privately held company dedicated to advancing women’s health with innovative solutions, announced today the appointment ...
Santé log

Zevra Therapeutics, Inc. Announces CFO Transition

Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra or the Company), a commercial-stage company focused on providing therapies for people living with rare disease, announced today that its Chief ...
Santé log

SEQUANA MEDICAL ANNOUNCES THE ISSUANCE OF A SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM

Ghent - Belgium, Nov. 20, 2025 (GLOBE NEWSWIRE) -- SEQUANA MEDICAL ANNOUNCES THE ISSUANCE OF A SUBSCRIPTION REQUEST NOTICE UNDER THE SHARE SUBSCRIPTION FACILITY AGREEMENT WITH GEM ...
Santé log

Clene to Participate at the Benchmark 14th Annual Discovery One-on-One Investor Conference

Conference Details Date: December 4, 2025 Location: New York, New York Format: 1x1 meetings (contact your Benchmark Representative) ...
Santé log

Syncromune®, Inc. to Present Phase 1 Data Highlighting Resolution of Bone Metastases in Metastatic Prostate Cancer Patients at the Society of Urological Oncology 26th Annual ...

For more information about Syncromune®, Inc. please visit www.syncromune.com.
Santé log

Nasus Pharma Strengthens Leadership Team, Appointing Eyal Rubin as Executive Vice President and Chief Financial Officer

Mr. Rubin will lead and oversee Nasus Pharma’s financial operations, including corporate finance, financial planning, capital strategy, and investor relations, as the Company advances its pipeline of ...
Santé log

4DMT to Participate in 8th Annual Evercore Healthcare Conference

Archived copies of the webcast will be available for up to one year on the “Investors” section of the 4DMT website at https://ir.4dmoleculartherapeutics.com/events.
Santé log

23andMe Research Institute Helps Reconnect African Diaspora to Their Roots with Release of 250+ High-Resolution African Genetic Groups

While the vast majority of Black and African American 23andMe Research Institute members on the latest genotyping chip will receive one or more of these new groups, there is more work to do. The ...
Santé log

Shattuck Labs to Participate in Upcoming December Investor Conferences

Conference: Evercore ISI 8 th Annual HealthCONx Conference Format: Fireside chat with Umer Raffat and Jonathan Miller, Ph.D. and one-on-one meetings (Dec 3-4) Presenter: Taylor Schreiber, M.D., Ph.D., ...
Santé log

Hydreight Technologies Ranked #77 Fastest-Growing Company in North America on the 2025 Deloitte Technology Fast 500™

Now in its 31st year, the Deloitte Technology Fast 500 provides a ranking of the fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies — both public ...